Onsolis Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

Onsolis General Information

Description

The opioid analgesic brand is indicated in the management of persistent breakthrough pain, in cancer patients who have already received and are tolerant to opioid therapy for their underlying cancer pain.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Corporate Office
  • United States
Primary Industry
Buildings and Property
Acquirer
Vertical(s)
Corporate Office
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Onsolis Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Onsolis‘s full profile, request access.

Request a free trial

Onsolis FAQs

  • Where is Onsolis headquartered?

    Onsolis is headquartered in .

  • What industry is Onsolis in?

    Onsolis’s primary industry is Buildings and Property.

  • Is Onsolis a private or public company?

    Onsolis is a Private company.

  • What is Onsolis’s current revenue?

    The current revenue for Onsolis is .

  • When was Onsolis acquired?

    Onsolis was acquired on 02-Aug-2023.

  • Who acquired Onsolis?

    Onsolis was acquired by Adalvo.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process